Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Insulin Dependent Diabetes Mellitus
53%
Adolescent
38%
Obesity
37%
Secretion (Process)
34%
Oral Glucose Tolerance Test
33%
Dysglycemia
33%
Cell Function
33%
Prevalence
32%
Insulin Resistance
30%
Insulin Release
29%
Glucose Tolerance
28%
Growth Hormone
26%
Gender Identity Disorder
26%
Hormone Therapy
26%
Hypoglycemia
26%
Cardiovascular System
26%
Body Mass Index
17%
Luteinizing Hormone
17%
Pediatrics Patient
16%
Insulin Treatment
15%
Insulin Sensitivity
15%
Diabetes
13%
Human Growth Hormone
11%
C-Peptide
10%
Insulin Response
10%
Glycemic Control
9%
Impaired Glucose Tolerance
8%
Pediatrics
7%
Antidiabetic Agent
7%
Glycemic
7%
Beta Cell
5%
Polycystic Ovary Syndrome
5%
Epigenomics
5%
Insulin Sensitizing Agent
5%
Nonalcoholic Fatty Liver
5%
Metabolic Syndrome
5%
Retrospective Study
5%
Lipodystrophy
5%
Keyphrases
Juvenile Type
29%
Type I Diabetes
26%
Type 1 Diabetes Mellitus (T1DM)
26%
Prolactin
26%
Dysphoric
26%
Isolated GH Deficiency
26%
Radioimmunoassay
26%
CD28
26%
Hamster
26%
Early-onset Type 2 Diabetes
26%
Disease Duration
26%
CD8+ T Cells
26%
Pulse Amplitude
26%
Gender Dysphoria
26%
Pituitary
26%
Disposition Index
26%
Cell Dynamics
26%
Physiological Changes
26%
Baseline Characteristics
26%
Ontogenesis
26%
Corticotrope
26%
Female-to-male
21%
Pars Distalis
19%
Sensitivity Relationships
15%
CD27
13%
Pediatric Patients
10%
Pediatric Endocrine
9%
Obesity-induced Insulin Resistance
6%
Syndrome Metabolic
6%
Multiorgan Effects
6%
Physiological Growth
6%
Prepubertal children
5%
Body Mass Index
5%
Initial Manifestation
5%
Limited Information
5%
Body Mass Index Percentile
5%
High Prevalence
5%
Adverse Health Consequences
5%
Potential Risk
5%
Basal LH
5%
Retrospective Chart Review
5%
Female Youth
5%
Female Patients
5%
HbA1c Levels
5%
High Incidence
5%
Overweight or Obesity
5%
FSH Secretion
5%
Nursing and Health Professions
Non Insulin Dependent Diabetes Mellitus
91%
Oral Glucose Tolerance Test
57%
Glucose Blood Level
55%
Dysglycemia
53%
Glucose Tolerance
52%
Obesity
37%
C Peptide
30%
Adolescent
28%
Gender Dysphoria
26%
Growth Hormone Deficiency
26%
Gonadorelin
26%
Gonadotropin
26%
Hypoglycemia
26%
Linear Regression Analysis
26%
Body Mass
17%
Insulin Treatment
12%
Pediatrics Patient
10%
Antidiabetic Agent
7%
Hospital
5%
Female Patient
5%
Prevalence
5%
Gonadotropin Deficiency
5%